CoChat
Sign Up
Cited by 20

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Altered amyloid precursor protein processing regulates glucose uptake and oxidation in cultured rodent myotubes

Hamilton, D. Lee, Findlay, John A., Montagut, Gemma, Meakin, Paul J., Bestow, Dawn, Jalicy, Susan M., Ashford, Michael L. J.·2014·Diabetologia
DOI 10.1007/s00125-014-3269-xPMC PMC4079947
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00125-014-3269-x

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • APP processing in C2C12 myotubes directly affects glucose uptake and GLUT4 translocation.

    “This is supported by the findings that APP processing in C2C12 myotubes directly affects glucose uptake and GLUT4 translocation.”

    From BACE1: More than just a β‐secretase (2022) · cites this paper as [103]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 37

  1. Fink RI, Wallace P, Brechtel G, Olefsky JM (1992) Evidence that glucose transport is rate-limiting for in vivo glucose uptake. Metabolism 41:897–902 · DOI
  2. Butler PC, Kryshak EJ, Marsh M, Rizza RA (1990) Effect of insulin on oxidation of intracellularly and extracellularly derived glucose in patients with NIDDM. Evidence for primary defect in glucose transport and/or phosphorylation but not oxidation. Diabetes 39:1373–1380 · DOI
  3. Petersen KF, Hendler R, Price T et al (1998) 13C/31P NMR studies on the mechanism of insulin resistance in obesity. Diabetes 47:381–386 · DOI
  4. Cline GW, Petersen KF, Krssak M et al (1999) Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. N Engl J Med 341:240–246 · DOI · Paper page
  5. Huang S, Czech MP (2007) The GLUT4 glucose transporter. Cell Metab 5:237–252 · DOI
  6. Pedersen O, Bak JF, Andersen PH et al (1990) Evidence against altered expression of GLUT1 or GLUT4 in skeletal muscle of patients with obesity or NIDDM. Diabetes 39:865–870 · DOI · Paper page
  7. Zierath JR, He L, Gumà A, Odegoard Wahlström E, Klip A, Wallberg-Henriksson H (1996) Insulin action on glucose transport and plasma membrane GLUT4 content in skeletal muscle from patients with NIDDM. Diabetologia 39:1180–1189 · DOI · Paper page
  8. Garvey WT, Maianu L, Zhu JH, Brechtel-Hook G, Wallace P, Baron AD (1998) Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance. J Clin Invest 101:2377–2386 · DOI · Paper page
  9. Zisman A, Peroni OD, Abel ED et al (2000) Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nat Med 6:924–928 · DOI · Paper page
  10. Leturque A, Loizeau M, Vaulont S, Salminen M, Girard J (1996) Improvement of insulin action in diabetic transgenic mice selectively overexpressing GLUT4 in skeletal muscle. Diabetes 45:23–27 · DOI
  11. Strachan MW, Reynolds RM, Marioni RE, Price JF (2011) Cognitive function, dementia and type 2 diabetes mellitus in the elderly. Nat Rev Endocrinol 7:108–114 · DOI
  12. LaFerla FM, Green KN, Oddo S (2007) Intracellular amyloid-β in Alzheimer’s disease. Nat Rev Neurosci 8:499–509 · DOI · Paper page
  13. Turner PR, O’Connor K, Tate WP, Abraham WC (2003) Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory. Prog Neurobiol 70:1–32 · DOI
  14. Meakin PJ, Harper AJ, Hamilton DL et al (2012) Reduction in BACE1 decreases body weight, protects against diet-induced obesity and enhances insulin sensitivity in mice. Biochem J 441:285–296 · DOI · Paper page
  15. Krook A, Wallberg-Henriksson H, Zierath JR (2004) Sending the signal: molecular mechanisms regulating glucose uptake. Med Sci Sports Exerc 36:1212–1217 · DOI
  16. Abdul-Ghani M, DeFronzo RA (2010) Pathogenesis of insulin resistance in skeletal muscle. J Biomed Biotechnol. doi: 10.1155/2010/476279 · DOI · Paper page
  17. Koistinen HA, Zierath JR (2002) Regulation of glucose transport in human skeletal muscle. Ann Med 34:410–418 · DOI
  18. Mowrer KR, Wolfe MS (2008) Promotion of BACE1 mRNA alternative splicing reduces amyloid beta-peptide production. J Biol Chem 283:18694–18701 · DOI · Paper page
  19. Wang Q, Khayat Z, Kishi K, Ebina Y, Klip A (1998) GLUT4 translocation by insulin in intact muscle cells: detection by a fast and quantitative assay. FEBS Lett 427:193–197 · DOI
  20. Sankaranarayanan S, Price EA, Wu G et al (2008) In vivo beta-secretase 1 inhibition leads to brain Abeta lowering and increased alpha-secretase processing of amyloid precursor protein without effect on neuregulin-1. J Pharmacol Exp Ther 324:957–969 · DOI
  21. Turinsky J, O’Sullivan DM, Bayly BP (1990) 1,2-Diacylglyceral and ceramide levels in insulin-resistant tissues of the rat in vivo. J Biol Chem 265:16880–16885 · DOI
  22. Adams JM 2nd, Pratipanawatr T, Berria R et al (2004) Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. Diabetes 53:25–31 · DOI
  23. Woods NK, Padmanabhan J (2013) Inhibition of amyloid precursor protein processing enhances gemcitabine-mediated cytotoxicity in pancreatic cancer cells. J Biol Chem 288:30114–30124 · DOI
  24. Ishiki M, Klip A (2005) Minireview: recent developments in the regulation of glucose transporter-4 traffic: new signals, locations and partners. Endocrinology 146:5071–5078 · DOI · Paper page
  25. Del Prato S, Matsuda M, Simonson DC et al (1997) Studies on the mass action effect of glucose in NIDDM and IDDM: evidence for glucose resistance. Diabetologia 40:687–697 · DOI
  26. Ciaraldi TP, Mudallar S, Barzin A (2005) Skeletal muscle GLUT1 transporter protein expression and basal leg glucose uptake are reduced in type 2 diabetes. J Clin Endocrinol Metab 90:352–358 · DOI
  27. Vingtdeux V, Marambaud P (2012) Identification and biology of α-secretase. J Neurochem 120(Suppl 1):34–45 · DOI
  28. Jimenez S, Torres M, Vizuete M et al (2011) Age-dependent accumulation of soluble amyloid β (Aβ) oligomers reverses the neuroprotective effect of soluble amyloid precursor protein-α (sAPPα) by modulating phosphatidylinositol 3-kinase (PI3K)/Akt-GSK-3β pathway in Alzheimer mouse model. J Biol Chem 286:18414–18425 · DOI
  29. Mattson MP, Guo ZH, Geiger JD (1999) Secreted form of amyloid precursor protein enhances basal glucose and glutamate transport and protects against oxidative impairment of glucose and glutamate transport in synaptosomes by a cyclic GMP-mediated mechanism. J Neurochem 73:532–537 · DOI
  30. Rossjohn J, Cappal R, Fell SC et al (1999) Crystal structure of the N-terminal, growth factor-like domain of Alzheimer amyloid precursor protein. Nat Struct Biol 6:327–331 · DOI
  31. Eckardt K, Taube A, Eckel J (2011) Obesity-associated insulin resistance in skeletal muscle: role of lipid accumulation and physical inactivity. Rev Endocr Metab Disord 12:163–172 · DOI
  32. Samuel VT, Shulman GI (2012) Mechanisms for insulin resistance: common threads and missing links. Cell 148:852–871 · DOI · Paper page
  33. Samuel VT, Petersen KF, Shulman GI (2010) Lipid-induced insulin resistance: unraveling the mechanism. Lancet 375:2267–2277 · DOI · Paper page
  34. Szendroedi J, Schmid AI, Chmelik M et al (2007) Muscle mitochondrial ATP synthesis and glucose transport/phosphorylation in type 2 diabetes. PLoS Med 4:e154 · DOI · Paper page
  35. Kelley DE, Mandarino LJ (2000) Fuel selection in human skeletal muscle in insulin resistance: a reexamination. Diabetes 49:677–683 · DOI · Paper page
  36. Jiménez-Palomares M, Ramos-Rodríguez JJ, López-Acosta JF et al (2012) Increased Aβ production prompts the onset of glucose intolerance and insulin resistance. Am J Physiol Endocrinol Metab 302:E1373–E1380 · DOI
  37. Zhang Y, Zhou B, Deng B et al (2013) Amyloid-β induces hepatic insulin resistance in vivo via JAK2. Diabetes 62:1159–1166 · DOI

Cited by

Sorted by citations

Metadata

Authors
Hamilton, D. L., Findlay, J. A., Montagut, G., Meakin, P. J., Bestow, D., Jalicy, S. M., & Ashford, M. L. J.
Venue
Diabetologia
Publisher
Springer Science and Business Media LLC
Published
2014-05-22
Volume
57
Issue
8
Pages
1684-1692
ISSN
  • 0012-186X
  • 1432-0428
DOI
10.1007/s00125-014-3269-x
PMC
PMC4079947
Cited by
20
References
11
Language
en
Licence
creativecommons.org/licenses/by/4.0 (unspecified)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review